Hogner A, Al-Batran SE, Siveke JT, Lorenz M, et al. Pazopanib with 5-FU and oxaliplatin as first line therapy in advanced gastric cancer: a randomized phase-II study - the PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO-STO-0510. Int J Cancer 2021 Nov 6. doi: 10.1002/ijc.33864.
PMID: 34741530